ABVC BioPharma, Inc.
NASDAQABVC BioPharma enters its May 22 earnings release with short sellers pulling back sharply — the clearest positioning signal ahead of the print. Short interest has fallen nearly 38% over the past month to 1.2% of the free float. That is a low absolute level, and the direction reinforces it: bears have been covering rather than pressing. Borrow conditions offer no extra ammunition…
Snapshot as of 20 May 2026
ABVC BioPharma enters its May 22 earnings release with short sellers pulling back sharply — the clearest positioning signal ahead of the print. Short interest has fallen nearly 38% over the past month to 1.2% of the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ABVC — free to start on ORTEX.
Sign up for free →Open ABVC on ORTEX